Theratechnologies Inc.
NASDAQ:THTX
1.72 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Theratechnologies Inc. |
Symbool | THTX |
Munteenheid | USD |
Prijs | 1.72 |
Beurswaarde | 79,085,628 |
Dividendpercentage | 0% |
52-weken bereik | 1.08 - 2.18 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Paul Lévesque |
Website | https://www.theratech.com |
An error occurred while fetching data.
Over Theratechnologies Inc.
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)